Lisa Paul - Pulmonx Corp Chief Officer

LUNG Stock  USD 5.90  0.01  0.17%   

Insider

Lisa Paul is Chief Officer of Pulmonx Corp
Age 60
Address 700 Chesapeake Drive, Redwood City, CA, United States, 94063
Phone650 364 0400
Webhttps://pulmonx.com

Pulmonx Corp Management Efficiency

The company has return on total asset (ROA) of (0.2052) % which means that it has lost $0.2052 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4617) %, meaning that it created substantial loss on money invested by shareholders. Pulmonx Corp's management efficiency ratios could be used to measure how well Pulmonx Corp manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.36. The current Return On Capital Employed is estimated to decrease to -0.42. At this time, Pulmonx Corp's Asset Turnover is most likely to slightly decrease in the upcoming years.
Pulmonx Corp currently holds 41.42 M in liabilities with Debt to Equity (D/E) ratio of 0.15, which may suggest the company is not taking enough advantage from borrowing. Pulmonx Corp has a current ratio of 9.24, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Pulmonx Corp's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 9 records

INSIDER Age

Peter MurphyTela Bio
51
Roberto JDTela Bio
56
Skott GreenhalghTela Bio
56
Ehab EsmailOrthofix Medical
52
BA ChemistryOrthofix Medical
63
Christopher SmithTela Bio
63
Paul TalmoTela Bio
N/A
Antony KoblishTela Bio
58
Mark QuickOrthofix Medical
N/A
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. Pulmonx Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 253 people. Pulmonx Corp (LUNG) is traded on NASDAQ Exchange in USA. It is located in 700 Chesapeake Drive, Redwood City, CA, United States, 94063 and employs 279 people. Pulmonx Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Pulmonx Corp Leadership Team

Elected by the shareholders, the Pulmonx Corp's board of directors comprises two types of representatives: Pulmonx Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pulmonx. The board's role is to monitor Pulmonx Corp's management team and ensure that shareholders' interests are well served. Pulmonx Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pulmonx Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steven Williamson, President CEO
David Lehman, General Secretary
Geoffrey Rose, Chief Officer
Lauren Cristina, VP Adm
John McKune, VP Controller
Sri Radhakrishnan, Chief Officer
Mehul Joshi, Chief Officer
Jrme Erath, Senior Africa
Marcee Maroney, Vice Marketing
Derrick Sung, Chief Officer
Glendon French, President CEO
Sarah Huber, Vice Sales
Lisa Paul, Chief Officer

Pulmonx Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pulmonx Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Pulmonx Stock

When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.54)
Revenue Per Share
1.909
Quarterly Revenue Growth
0.297
Return On Assets
(0.21)
Return On Equity
(0.46)
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.